Development of contrast enhanced ultrasound molecular imaging for atherosclerosis risk assessment

• Unité de recherche: INNOSUISSE
• Numéro de projet: 120.781 IP-LS
• Titre du projet anglais: Development of contrast enhanced ultrasound molecular imaging for atherosclerosis risk assessment

Mots-clé (Anglais)

Life sciences, Medical diagnostics

Résumé des résultats (Abstract) (Anglais)

Myocardial infarction and stroke are leading causes of mortality, with 40% of adults at intermediate risk. Current risk stratification is insufficient. We propose to translate our novel pre-clinical diagnostic tool for accurate risk assessment and improved prevention of cardiovascular events.